Eli Lilly and Co. (LLY) announced that Steven Paul, executive vice president, science and technology, and president, Lilly Research Laboratories, will retire from Lilly effective February 28, 2010.
Lilly has also announced that Jan Lundberg, executive vice president and head of global discovery research, AstraZeneca, is to become his successor. Lundberg plans to join Lilly in Indianapolis as early as January 2010, subject to completion of the U.S. immigration process. Lundberg has a Ph.D. from Sweden's world-renowned Karolinska Institute, where he was a professor in the department of pharmacology before moving to industry. Prior to Karolinska, he attended Gustavus Adolphus College in Minnesota and the University of Gothenburg in Sweden. He has been a member of the Swedish Medical Research Council and also of the Advisory Board for Drug Approvals at the Swedish Medical Product Agency. In January 2003, he was appointed Honorary Doctor of Pharmacy at Uppsala University.
For the past seven years, Lundberg has been an executive vice president and member of the senior executive team.
For comments and feedback: editorial@rttnews.com